Modification of an outcome measure to follow symptoms of children with acute otitis media.
Nader Shaikh, Matthew C Lee, Marcia Kurs-Lasky
https://pubmed.ncbi.nlm.nih.gov/38961165Actively Recruiting
Led by Timothy Shope · Updated on 2026-01-07
300
Participants Needed
2
Research Sites
26 weeks
Total Duration
T
Timothy Shope
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
Researchers are evaluating the use of an artificial intelligence (AI) app to improve the diagnosis and treatment of ear infections in young children aged 6 to 24 months who have cold symptoms. Ear infections can be hard to diagnose accurately in this age group due to small ear canals and limited examination time. The study aims to see how the AI app affects clinical decisions about ear infections and antibiotic use compared to standard clinical exams. The study involves 300 children who will have their ears examined both with the AI app using a smartphone-attached otoscope and by a clinician using a standard otoscope. Each child will receive two ear exams during a single visit. The AI app records and analyzes images to provide a diagnosis and treatment recommendation, which is compared to the clinician's diagnosis. Clinicians will then review the AI app's findings before making a final treatment decision. The study uses a within-subject design where each child's ears are assessed by both methods to compare antimicrobial prescription rates and diagnosis accuracy. Participants will be monitored for 10 days after enrollment to track symptom changes and any side effects from antibiotic use, such as diarrhea or diaper rash. Parents will enter daily symptom scores in electronic diaries. Medical records will be reviewed for three months to identify any recurrences of ear infections. The primary outcome is the rate of antimicrobial prescriptions on the day of diagnosis. Secondary outcomes include diagnostic rates, image quality, symptom severity scores, and infection recurrences. The total study participation involves one visit for exams and follow-up symptom tracking and record review.
CONDITIONS
Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day visit
Participants undergo two ear exams: one with the AI app by study personnel and one standard clinical exam by the clinician, both blinded to each other's diagnosis. Diagnoses and treatment decisions are recorded for comparison.
1 visit (in-person)
Duration - 10 to 11 days
Participants' symptoms are monitored daily for 10 days using an electronic diary entered by parents. If symptoms worsen significantly, participants are contacted and offered a visit. Side effects of antimicrobial use are also assessed during this period.
Daily symptom reporting by parents (remote)
Duration - 3 months
Participants' medical records are reviewed for 3 months after enrollment to monitor for acute otitis media recurrences.
No visits; medical record review only
Total: 2 locations
1
Children's Community Pediatrics Brentwood
Pittsburgh, Pennsylvania, United States, 15227
Actively Recruiting
2
Children's Community Pediatrics Castle Shannon
Pittsburgh, Pennsylvania, United States, 15234
Actively Recruiting
T
Timothy R Shope, MD, MPH
N
Nader Shaikh, MD, MPH
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nader Shaikh, Matthew C Lee, Marcia Kurs-Lasky
https://pubmed.ncbi.nlm.nih.gov/38961165Noah Bedard, Timothy Shope, Alejandro Hoberman...
https://pubmed.ncbi.nlm.nih.gov/28101416Nader Shaikh, Shannon J Conway, Jelena Kovacevic...
https://pubmed.ncbi.nlm.nih.gov/38436941Anupama Kuruvilla, Nader Shaikh, Alejandro Hoberman...
https://pubmed.ncbi.nlm.nih.gov/23997759